大連立方化學(xué)已成為Mesalabs中國(guó)代理商
我們以質(zhì)的渠道為您提供質(zhì)的服務(wù)！
杜絕暴利，節(jié)約每一分科研經(jīng)費(fèi)！
大連立方化學(xué)能為用戶提供16%增值稅發(fā)票！
訂購(gòu)流程：咨詢客服確定產(chǎn)品→告知客服人員收貨開(kāi)票信息→確立合同→等待收貨
→轉(zhuǎn)賬付款
咨詢/訂購(gòu)電話：13504241390
手機(jī)：13504241390
微信號(hào)：13504241390
qq：3324578804
郵箱：dllfhxjs@126.com
Mesalabs是全球也是最為著名的生物指示產(chǎn)品的制造商，產(chǎn)品用于評(píng)估滅菌
過(guò)程，包括蒸汽，氣體，過(guò)氧化氫和輻射的功效化學(xué)指標(biāo)，廣泛應(yīng)用世界各地的醫(yī)院，牙科，
醫(yī)療器械和醫(yī)藥行業(yè)。在其發(fā)展過(guò)程中，先后購(gòu)并了該行業(yè)一些著名企業(yè)，Raven、
Apex（Apexlabs）、SGM（SGM Biotech），2012年Raven品牌停用，全部變更為Mesalabs。
所有Mesalabs產(chǎn)品目錄下的產(chǎn)品，我們均以質(zhì)的渠道、惠的價(jià)
格為您提供質(zhì)的服務(wù)！
NIBSC標(biāo)準(zhǔn)品 產(chǎn)品列表：
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
00/442 Influenza anti B/Yamanashi/166/98 Serum (sheep)
00/464 Streptokinase (3rd International Standard 2001)
00/500 Botulinum Type A-E Antitoxin, Human Serum
00/530 Influenza Virus infectious B/Sichuan/379/99
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
00/544 Influenza Virus infectious B/Victoria/504/00
00/546 Influenza Antigen B/Johannesburg/5/99
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
00/614 Influenza virus infectious B/Guangdong/120/2000
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
01/426 Meningococcal group Y polysaccharide
01/428 Meningococcal serogroup W polysaccharide
01/450 Influenza anti B/Guangdong/120/2000 Serum
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
01/506 Botulinum type F antitoxin, equine
01/508 Botulinum type C antitoxin, equine
01/510 Botulinum Antitoxin Equine Type D
01/512 Botulinum type G antitoxin, equine
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)
01/530 Oral Poliovaccine Sabin Type 2 reference strain (Panel of 5 ampoules)
01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
01/546 Influenza Antigen B/Guangdong/120/2000
01/572 Anti-D Immunoglobulin(2nd International Standard)
01/580 Thrombin, human(2nd International Standard)
01/600 Anti-Toxoplasma IgG, Human(International Standard)
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
01/612 Influenza Virus infectious B/Hawaii/10/01
01/614 Influenza Antigen A/New Caledonia/20/99
02/102 Influenza anti A/Panama/2007/99 Serum
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
02/180 Anti-Meningococcal Serotype P2.2a mAb
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
02/206 Factor XIII Plasma, Human (1st International Standard)
02/210 HIV (antibody), 1st International Reference Panel
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
02/230 Biotinylated Brad-5 (Bio-Brad-5)
02/232 Tetanus Toxoid (Non-Adsorbed)
02/254 Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)
02/262 Influenza Virus infectious B/Brisbane/32/2002
02/264-005 HCV RNA Working Reagent for Nucleic Acid Amplification Techniques
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
02/306 Polio Virus Sabin Types 1, 2 and 3(2nd International Reference Reagent)
02/308 Anti-Meningococcal Serotype P3.4 mAb
02/310 Anti-Meningococcal Serotype P3.15 mAb
02/318 Botulinum Antitoxin Equine Type E
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
02/336 Influenza Antigen A/New Caledonia/20/99
02/338 Influenza anti A/Panama/2007/99 Serum
02/342 Protein C Plasma, Human(2nd International Standard)
03/104-016 HTLV-1 (antibody) Monitor Sample
03/110 Influenza anti B/Shangdong/9/97 Serum
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
03/116 Blood Coagulation Factor V, Plasma Human (1st International Standard)
03/124 Thrombopoietin ( Human rDNA derived)
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
03/152 Anti-HPA-1a (International Standard)
03/164 Anti-B minimum potency reference preparation(International Standard)
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
03/182 Anti-Meningococcal Serotype P3.21 mAb
03/188 Anti-A minimum potency reference preparation(International Standard)
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
03/198 Influenza Virus infectious A/Kumamoto/102/02
03/200 Interleukin - 18 (Human rDNA derived)(International Reference Reagent)
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
03/212 Influenza anti A/Wyoming/03/03 Serum
03/220 Influenza Antigen A/Wyoming/03/03
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
03/228 Protein S, Plasma, Human(2nd International Standard)
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
03/244 Influenza Antiserum A/chick/Germany/N/49
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
04/102 Blood Coagulation Factor XI Plasma, Human(1st International Standard)
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
04/132 IVIG + Anti-D for use with negative control IVIG
04/140 IVIG Negative Control for use with IVIG & Anti-D
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
04/160 Influenza Virus infectious NYMC X-147
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
04/170 Influenza Virus infectious A/Wellington/1/2004
04/172 Influenza Virus infectious IVR-139
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
04/198 Anti-Meningococcal Serotype P3.1 mAb
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
04/202 Influenza Antigen B/ Jiangsu/10/2003
04/214 Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442)
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
04/228 Influenza anti B/ Neuraminidase Serum
04/230 Influenza anti N1 Neuraminidase Serum
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum (sheep)
04/246 Anti-Meningococcal Serogroup W-135 mAb
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
04/252 Protein C Concentrate, Human(1st International Standard)
04/258 Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003)
04/260 Influenza anti A/New Caledonia/20/99 HA Serum (sheep)
04/262 Influenza anti A/New York/55/2004 HA Serum (sheep)
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
05/102 Influenza Virus infectious NYMC BX-7
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
05/110 Influenza Virus infectious A/California/7/2004
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
05/122 Syphilitic plasma IgG (human)(1st International Standard)
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
05/132 Syphilitic plasma IgG and IgM (human)(1st International Standard)
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
05/138 Influenza Virus infectious B/Shanghai/361/2002
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
05/236 Influenza anti A/Wisconsin/67/2005 Serum (sheep)
05/242 IVIG, Anti-D and Negative Control Panel
05/252 Influenza anti B Neuraminidase Serum (Sheep SH463)
06/108 Influenza Virus infectious IVR-116
06/114 Influenza Virus Infectious A/PR/8/34
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
06/166 Antithrombin Concentrate, Human (3rd International Standard)
06/170 Influenza Antigen A/New Caledonia/20/99
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470)
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
07/132 Influenza Virus infectious B/Malaysia/2506/2004
07/144 Influenza Virus infectious IVR-145,
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
07/182 Blood Coagulation Factor IX Concentrate, Human (4th International Standard)
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum (sheep)
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
07/214 Positive Control for use in flow cytometry cross matching (FCXM)
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
07/222 RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
07/226 Influenza Virus Infectious A/New Caledonia/20/99
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
07/246 Influenza Virus Infectious IVR-147
07/268 Influenza Virus Infectious B/Brisbane/3/2007
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
07/286-012 Hepatitis B Surface Antigen Monitor Sample
07/288-012 Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
07/294-005 Norovirus GII for Nucleic Acid Amplification Techniques
07/296-005 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
07/298-004 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300-004 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
07/304 Anti-D for assuring operator and test performance
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
07/318 Meningococcal Group C Polysaccharide
07/326 Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard.
07/328 Unfractionated Heparin (6th I.S.)
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
07/338 Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477)
07/348 Influenza Virus infectious NYMC X-171B
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
07/358 Influenza Virus infectious NIB-50
07/362 Influenza Virus infectious IVR-149
07/364 Chorionic Gonadotrophin, (5th International Standard)
07/B498-16 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
08/108 Influenza Virus Infectious NIBRG-91
08/114-005 Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques
08/118-004 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120-005 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/126 Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485)
08/138 Influenza Virus Infectious B/Florida/4/2006
08/140 Influenza Antigen B/Florida/4/2006
08/142 Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477)
08/148 Positive control for Luminex based anti-HLA Class II serology
08/150 HIV-2 RNA(1st International Standard)
08/154 Influenza Virus Infectious NIBRG-12
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
08/174-006 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176-004 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178-004 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180-004 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/184 Influenza Antigen B/Malaysia/2506/2004
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
08/204 Thyroid Stimulating Antibody (2nd I.S.)
08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
08/224-005 Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques
08/226-005 Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
08/230 Streptodornase (2nd International Standard)
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
08/256 C1- Inhibitor, Concentrate (1st International Standard)
08/258 Antithrombin, Plasma (3rd International Standard)
08/262 C1 Inhibitor (Plasma)(1st International Standard)
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
08/300 Influenza Virus Infectious IVR-148
08/304 Influenza virus infectious NYMC X-175C
08/310-005 Varicella Zoster Virus(Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT)
08/314-006 Human Cytomegalovirus for Nucleic Acid Amplification Techniques (AD169)
08/316-005 Epstein-Barr Virus for Nucleic Acid Amplification Techniques
08/318-005 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320-007 Human metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/322-004 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
08/356 Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398)
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
09/130 Influenza Virus Infectious NIBRG-122
09/136 Granulocyte colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
09/154 Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
09/182 VWF Factor Concentrate (2nd International Standard)
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
09/222 Human anti-Haemophilus influenzae b reference serum
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
09/236 Influenza Virus Infectious IVR-153
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived
09/268 Influenza Virus Infectious NIBRG-121xp
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
09/274 Influenza Virus Infectious NYMC X-185
09/280 Influenza Virus Infectious NIB-64
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
09/304 Influenza Virus Infectious IVR-155
09/306 Influenza Virus Infectious NIBRG-147
09/308 Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A)
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
09/B558-06 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices
09/B584-12 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
09/B588-07 QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1
10/104 Reteplase Reference Material
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum (sheep 516 and 517)
10/128 Diphtheria Polyclonal Antibody
10/130 Diphtheria Monoclonal Antibody
10/132 Tetanus Polyclonal Antibody
10/134 Tetanus Monoclonal Antibody
10/136-001 HLA-DRB1 Genotyping Reference Panel
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
10/142 Negative control for Luminex based anti-HLA serology
10/152 HIV-1 RNA (3rd International standard)
10/154-005 Anti-HCV (1 in 8 dilution)(British Working Standard)
10/176 Interleukin-29 (Interferon Lamda 1)
10/178 Endotoxin (3rd International Standard)
10/188 Factor VIII Concentrate (13th British Standard).
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521)
10/226 Influenza Virus Infectious IVR-158
10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
10/252 Factor VII Concentrate(2nd International Standard)
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
10/260 Influenza Virus Infectious NIB-58
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
10/264 Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
10/276 Influenza virus infectious BX-31
10/276 Influenza virus infectious BX-31
10/280 Anti-HLA Control
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
10/B592-09 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
10/B594-06 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
10/B596-09 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
11/106 Influenza Virus infectious A/Perth/16/2009
11/106 Influenza Virus infectious A/Perth/16/2009
11/108 Influenza Virus infectious NYMC X-187
11/108 Influenza Virus infectious NYMC X-187
11/126 Factors II and X Concentrate (4th International standard)
11/130 Influenza Virus Infectious NIBRG-14
11/130 Influenza Virus Infectious NIBRG-14
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
11/176 Low Molecular Weight Heparin 2 (3rd International Standard)
11/182-001 HBV DNA Working Reagent
11/184 High Molecular Weight Urokinase(2nd International Standard)
11/206 Influenza anti-A/Perth/16/2009 HA Serum
11/208-001 Parvovirus B19 DNA
11/210 Anti-human CD4 FITC conjugated 0.5ml
11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel
11/222 Influenza Virus Infectious NIB-79
11/226 Influenza Virus Infectious A/Victoria/361/2011
11/232 Influenza Virus Infectious B/Texas/6/2011
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
11/244 Influenza Virus Infectiious NYMC BX-49
11/B601-05 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
11/B603-06 QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2
11/B604-002 QCRFLUAH5QC1 Influenza H5 PC1
11/B606-05 QCRNEGQC1-Negative Quality Control Serum: Sample1
11/B608-02 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
12/100 Influenza Virus Infectious NYMC X-217
12/104 International Standard for IPV 12/104 (3rd International Standard)
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
12/122 Influenza virus infectious A/turkey/Italy/3889/1999
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
12/168 Influenza Antigen A/California/7/09 (H1N1) (NYMCX-181) Egg derived
12/172 3rd HCV RNA Genotype Panel for Nucleic acid amplification techniques
12/174 Infectious Virus Influenza A/California/7/2009
12/176 Methylated Human Serum Albumin (mHSA)
12/188 Pegylated Granulocyte colony Stimulating Factor (Human, rDNA derived) (International Standard)
12/196-001 Hereditary Haemochromatosis Genotyping Reference Panel
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
12/200 Influenza virus infectious B/Brisbane/60/2008 34500 E7
12/202 Influenza virus infectious NYMC BX-39
12/204 Influenza Virus infectious IVR-165
12/208 Parvovirus B19 (3rd International Standard)
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
12/248-001 JAK2 V617F Genotyping Sensitivity Panel
12/252 ADAMTS 13 Plasma (1st International Standard)
12/282 Diphtheria Toxin 1Lf/ml
12/284 Anti-meningococcal serogroup Y monoclonal antibody
12/290 Influenza Virus Infectious B/Brisbane/36/2012
12/294 Influenza Virus Infectious NYMC BX-51C
12/298 Influenza Virus Infectious A/Texas/50/2012
12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
12/B611-02 Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1
12/B612-04 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
12/B613-03 QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2
12/B614-05 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
12/B620-04 QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
12/B622-06 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
12/B623-003 QCRFLUAH1N1QC1-Influenza AH1N1 QC1
13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
13/102-001 Hepatitis A Virus RNA Working Reagent
13/106 Influenza Antigen B/Massachusetts/02/2012
13/108 Anti-Meningococcal serogroup B monoclonal antibody
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
13/132 Anti-Toxoplasma IgM Human. (4th International Standard).
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
13/146 C-Peptide, Human. 1st International Standard.
13/152 Influenza Antigen B/Massachusetts/02/2012 (cell derived)
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
13/168-001 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
13/172 Lupus Anticoagulant (1st International Reference Panel)
13/176 Influenza Virus Infectious NIBRG-88
13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
13/180 Influenza A/Anhui/1/2013 (H7) HA Serum
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
13/198 Influenza Virus Infectious NYMC X-181
13/200 Influenza Virus Infectious NIB-74
13/202 Influenza Virus Infectious NIB-74xp
13/206 Plasmin (4th International Standard)
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
13/218 Polio Anti Sabin type 1 (inactivated) Serum
13/220 Polio Anti Sabin type 2 (inactivated) serum
13/222 Polio Anti Sabin type 3 (inactivated) serum
13/224 Influenza virus Infectious NIB-85. 36210 E5
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
13/234 Influenza antigen B/Brisbane/60/08
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
13/246 Meningococcal serogroup A polysaccharide. 1st WHO International Standard.
13/248 Influenza virus infectious NIBRG-267
13/250 Influenza Virus Infectious NIBRG-268
13/252 Influenza virus infectious NYMC X-223A
13/254 Influenza Anti-B/Brisbane/60/2008-HA serum
13/256 Influenza virus infectious. NYMC x-233
13/258 Influenza virus infectious NYMC X-233A
13/264 Influenza Virus Infectious NYMC X-223
13/B625-04 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2
13/B627-03 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
13/B629-03 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1
13/B631-03 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
13/B634-02 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
13/B636-03 QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2
13/B638-03 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2
13/B640-01 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5
13/B642-04 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
13/B644-01 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3
13/B650-01 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1
14/106 Influenza virus infectious. NYMC BX-51B
14/114 JC Virus (JCV) International Standard.
14/116 Influenza virus infectious NYMC X-179A
14/118 Influenza virus infectious B/Massachusetts/2/2012
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) (sheep SH598)
14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)
14/148 Human Coagulation Factor IX Concentrate. 5th International Standard.
14/150 Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)
14/154 Influenza virus infectious. NYMC BX-35
14/156 Meningococcal group X polysaccharide. 1st WHO International Standard.
14/160 High titre anti-A in IVIG working reference reagent
14/198-001 HBV,HCV,HIV Multiplex
14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)
14/204 Influenza Virus Infectious B/Brisbane/9/2014
14/206 Influenza virus infectious NYMC X-247
14/212 BK Virus (BKV) International Standard
14/224 Influenza virus infectious. A/Switzerland/9715293/2013
14/226 Influenza Virus Infectious A/South Australia/55/2014
14/228 Influenza Virus Infectious A/Stockholm/6/2014
14/230 Influenza Virus Infectious. A/Norway/466/2014
14/232 Influenza Virus Infectious IVR-175
14/240-002 British Working Standard for Anti-HCV
14/248 Influenza Anti-B/Phuket/3073/2013 HA serum
14/250 Influenza Antigen. A/Anhui/1/2013 (H7N9) NIBRG-268
14/252 Influenza Antigen B/Phuket/3073/2013
14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)
14/266 Diphtheria Antitoxin Equine (DI) 1st International Standard
14/272 Influenza Anti-A/Switzerland/9715293/2013-like HA serum
14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)
14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
14/300 High titre anti-A and anti-B in serum. WHO Reference Reagent.
14/306 Influenza Virus Infectious NYMC X-243 40180 E13
14/308 Influenza Virus Infectious IVR-178 40200 E7
14/310 Influenza anti-A/California/7/09 HA serum
14/312 Influenza Virus Infectious B/Phuket/3073/2013
14/314 Influenza Virus Infectious NIB-88
14/320 Influenza Virus Infectious B/Utah/9/2014
14/322 Influenza Virus Infectious NIB-91
14/B651-01 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2
14/B653-01 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
14/B654-01 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1
14/B655-01 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)
15/104 Influenza Antigen A/South Australia/55/2014 Cell derived
15/136 EBOV RNA NP-VP35-GP in-run control
15/138 EBOV RNA VP40-L in-run control
15/148 Influenza Virus Infectious NIB-92
15/154 Influenza Virus Infectious NIB-93
15/158 Influenza Virus Infectious NYMC X-263
15/184 Influenza Virus Infectious NYMC X-263B
15/188 Influenza Virus Infectious NYMC X-263A
15/192 Influenza Virus Infectious A/Hong Kong/4801/2014
15/194 Influenza Virus Infectious NYMC X-257A
15/196 Influenza Virus Infectious NYMC X-261
15/212 Influenza Virus Infectious NYMC BX-53C
15/220 Anti-EBOV plasma, human WHO Reference Reagent
15/222 EBOV RNA NP-VP35-GP WHO Reference Reagent
15/224 EBOV RNA VP40-L WHO Reference Reagent
15/230 Influenza Antigen A/Hong Kong/4801/2014 (NYMCX-263B) (Egg derived antigen)
15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7
15/236 Influenza Anti-A/Hong Kong/4801/2014 Like HA serum (sheep 640,641,642,643)
15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)
15/B658-01 QCRLYMEQC1 - Anti-Lyme QC1
15/B661-01 IgM Anti-Lyme QC1
15/B664-01 Anti-MumpsQC1
15/B667-01 QCRMEASQC1 Anti-MeaslesQC1
234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)
2BADS Anti-Brucella Abortus Serum, Bovine (International Standard)
2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard)
2CPEPSILONAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)
520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)
59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine
59/016 Corticotrophin (ACTH), Porcine (3rd International Standard)
59/021 Botulinum Antitoxin Equine Type A
60/001 Botulinum Antitoxin Equine Type B
60/013 Tetanus Antitoxin, Equine, for Bioassay
61/001 Botulinum Antitoxin Equine Type D (1st International Standard)
62/001 Serum Gonadotrophin, Equine (2nd International Standard)
62/014 Lysine Vasopressin, Porcine
63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine
63/007 Diphtheria Antitoxin, Equine, for Flocculation Test
64/002 Rheumatoid Arthritis Serum
64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine
64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine
65/093 Anti-Thyroglobulin Serum, Human (International Reference reagent)
65/119 Renin, Porcine
65/122 Long-acting Thyroid Stimulator, Human
66/021 Tetanus Antitoxin, Equine, for Flocculation Test
66/138 Gastrin II, Porcine
66/153 Diphtheria Antitoxin, Equine
66/233 Anti-Nuclear Factor Serum (Homogenous) Human
66/387 Anti-thyroid Microsome Serum, Human
67/037 Immunoglobulin D (IgD) Serum, Human
67/086 Immunoglobulins G, A, M Serum Human (International Standard)
67/099 Immunoglobulins G, A & M Serum Human
67/182 Anti-Rubella Serum, Human
67/183 Primary Biliary Cirrhosis Serum, Human
68/340 Anti-Nucleolar Factor Plasma, Human
68/356 Renin, Human (International Standard)
69/017 Diphtheria Toxoid, Plain
69/065 Autoimmune Antibody to Human Spermatazoa
69/194 Glucagon, Porcine (First International Standard)
70/302 Angiotensin II (25µg)
71/328 Angiotensin I
73/515 Anti-D (Rho) Antibodies, Human
73/545 Placental Lactogen, Human (International Reference Preparation)
73/554 Cholera Vaccine (Inaba)
73/556 Cholera Vaccine (Ogawa)
73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
74/520 Serum Proteins (Other than Immunoglobulins) Human
74/555 Corticotrophin (ACTH), Human
74/581 Ancrod (1st International Reference Preparation)
74/586 Corticotrophin (ACTH), Porcine
75/506 Cocksfoot Pollen Extract
75/533 Chorionic Gonadotrophin, Human, for Radioiodination
75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination
75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)
75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)
75/595 Blood Coagulation Factor Xa, Bovine
76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination
76/515 Mannan (C. Albians) Purified
76/522 Opacity 5IRP
76/525 Anti-Birch Pollen Serum, Human
76/547 Influenza anti A/Victoria/3/75 Serum(goat)
76/575 Oxytocin(4th International Standard)
77/503 Anti-Cocksfoot Serum, Human
77/512 Lysine Vasopressin(1st International Standard)
77/530 Influenza Antigen A/New Jersey/8/76
77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum(sheep)
77/568 Influenza anti B/Hong Kong/8/73 Serum(sheep)
77/584 Anti-D Pteronyssinus Serum, Human
77/600 Mannan (C. Albicans) Purified
77/616 Twelve Grass Pollen Extract
77/643 Secretin
77/662 Acarus Siro Extract
77/664 Glycyphagus destructor Extract
78/517 Tyrophagus Putrescentiae Extract
78/543 Kininogenase, Porcine
78/545 Anti-Aspergillus fumigatus Serum, Human
78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard)
78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard)
78/560 Influenza Antigen A/Texas/1/77
78/569 Influenza anti A/Texas/1/77 Serum (sheep)
78/575 Aspergillus Fumigatus Extract
78/582 Tyrophagus Longior Extract
78/628 Bee Venom
79/500 Parathyroid Hormone, Human (1st International Ref. Preparation)
79/516 Influenza anti A/Brazil/11/78 Serum (goat)
79/552 Influenza Antigen A/USSR/92/77
79/558 Influenza Antigen A/USSR/92/77
79/560 Influenza Antigen A/Brazil/11/78
79/568 Influenza Antigen B/Hong Kong/8/73
79/572 Prekallikrein Activator (PKA), Human
80/505 Growth Hormone, Human, Pituitary
80/517 Influenza Antigen A/Bangkok/1/79
80/519 Influenza Antigen B/Singapore/222/79
80/523 Influenza anti B/Singapore/222/79 Serum
80/525 Influenza anti A/Bangkok/1/79 Serum (sheep)
80/590 Tetracosactide
81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard)
81/565 Thyroid Stimulating Hormone, Human
82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment
82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment
82/518 Dermatophagoides Pteronyssinus Extract
82/520 Timothy Pollen Extract
82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)
82/587 Interferon Gamma (Human, Leukocyte derived)
82/632 Parathyroid Hormone, Bovine
82/652 Human Serum Vitamin B12, Pernicous anaemia
83/500 Insulin, Human
83/501 Beta Thromboglobulin, Purified Human
83/505 Platelet Factor 4 Human, Purified
83/511 Insulin, Bovine
83/514 Interferon alpha-1D, (Human rDNA derived)
83/515 Insulin, Porcine
83/537 Influenza Antigen A/Philippines/2/82
83/545 Influenza anti A/Philippine/2/82 Serum (sheep)
83/550 Influenza Antigen A/Brazil/11/78
83/575 Follicle Stimulating Hormone, Pituitary
84/500 Prolactin, Human
84/514 Proinsulin, Bovine
84/522 Birch Pollen Extract
84/528 Proinsulin, Porcine
84/538 Influenza Antigen A/Chile/1/83
84/542 Influenza Antigen B/Norway/1/84
84/581 Short Ragweed Pollen Extract
84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin)
84/628 Anti-c Serum, Human
84/636 Influenza anti B/USSR/100/83 Serum(sheep)
84/640 Influenza anti A/Chile/1/8 Serum(sheep)
84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)
84/685 Dog (Canis Familiaris) Hair Dander Extract
85/506 C-Reactive Protein, Human
85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum (sheep)
85/520 Influenza Antigen A/Equine/Kentucky/1/81
85/522 Thyroid Stimulating Hormone beta subunit
85/551 Anti-Rye Grass Serum, Human
85/616 Haemoglobin F Lysate, Raised
85/669 Atrial Natriuretic Factor, Human
86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard)
86/536 Angiotensin I Human Type Synthetic
86/538 Angiotensin II (2.5µg)
86/552 Interleukin-1 Beta (Human, rDNA derived)
86/576 Influenza Antigen A/Mississippi/1/85
86/590 Influenza anti A/Mississippi/1/85 Serum(sheep)
86/592 Influenza anti B/Ann Arbor/1/86/HA Serum (sheep)
86/630 Influenza Antigen B/Ann Arbor/1/86
86/632 Interleukin-1 alpha (Human rDNA derived)
86/678 Interleukin-1 alpha (Human, rDNA derived)
86/680 Interleukin-1 beta (Human, rDNA derived)
86/690 Inhibin, Porcine
87/510 Influenza Antigen A/Equine/Miami/63
87/578 Influenza anti A/Leningrad/360/86 Serum (sheep)
87/584 Influenza Antigen A/Leningrad/360/86
87/586 Interferon Gamma (Human, rDNA derived)
87/640 Tumour Necrosis Factor beta (Human, rDNA derived)
87/654 Anti-Ferritin Monoclonal Antibody (1)
87/662 Anti-Ferritin Monoclonal Antibody (2)
87/714 Influenza Antigen A/Sichuan/2/87
87/774 Influenza Antigen B/Victoria/2/87
88/522 Bordetella pertussis (Whole cell vaccine) 3BRP
88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived)
88/554 Influenza Antigen B/Beijing/1/87
88/556 Calcitonin, Eel
88/638 Thyroxine-binding globulin
88/646 Granulocyte Macrophage colony Stimulating Factor (Human, rDNA derived)
88/654 Influenza Antigen A/England/427/88
88/656 Interleukin-4 (Human, rDNA derived)
88/672 Influenza anti A/Sichuan/2/87 Serum(sheep)
88/678 Influenza anti B/Beijing/1/87 Serum(sheep)
88/846 Influenza anti A/England/427/88 Serum(sheep)
89/512 Macrophage colony Stimulating Factor (CSF-1) (Human rDNA derived)
89/514 Transforming Growth Factor beta-1 (Human, rDNA derived)
89/516 Transforming Growth Factor beta-1 (Bovine)
89/518 Transforming Growth Factor beta-2 (Bovine)
89/520 Interleukin-8 (Human, rDNA derived)
89/530 Anti-Bordetella pertussis serum (Human)
89/544 Renin, Human, rec DNA
89/548 Interleukin-6 (Human, rDNA derived)
89/568 Influenza Antigen A/OMS/5389/88
89/594 Bordetella pertussis (W28) LPS 2ug
89/596 Bordetella pertussis anti-agglutinogen 1(rabbit)
89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit)
89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit)
89/620 Calcitonin, Human
89/666 Haemoglobin A2 Lysate, Raised
89/670 Bordetella pertussis (W28) LPS25ug
90/500 Influenza Antigen A/Shanghai/16/89
90/502 Influenza Antigen A/Guizhou/54/89
90/504 Influenza anti A/Guangdong/39/89 Serum(sheep)
90/520 Bordetella pertussis, filamentous haemagglutinin (FHA)
90/530 Interleukin-7 (Human, rDNA derived)
90/534 Mumps Vaccine (Live)
90/586 Interleukin-5 (Human, rDNA derived)
90/636 HIV-1 P24 Antigen
90/654 Bordetella pertussis 69kD
90/690 Anti-Varicella-Zoster Antibody
90/696 Transforming Growth Factor beta-2, Human, rec DNA
90/712 Basic Fibroblast Growth Factor (Human, rDNA derived)
90/784 Influenza Virus infectious NIB-26 (H3N2)
91/510 Interleukin-3 (Human, rDNA derived)
91/530 Epidermal Growth Factor (Human, rDNA derived)
91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived)
91/554 Insulin-like growth Factor 1
91/562 Anti-D for use with papain preparation 92/658
91/612 Influenza anti A/Taiwan/1/86 Serum (sheep)
91/624 Inhibin A, Human, recombinant
91/626 Activin A, Human, Recombinant
91/656 Interleukin-4 (Mouse, rDNA derived)
91/658 Granulocyte Macrophage colony Stimulating Factor (Mouse rDNA derived)
91/662 Interleukin-3 (Mouse, rDNA derived)
91/670 Influenza Virus infectious NIB-27 (H1N1)
91/678 Interleukin-9 (Human,rDNA derived)
91/682 Stem Cell Factor (Human rDNA derived)
91/688 Rubella Vaccine (Live)
92/510 Follicle Stimulating Hormone, Human, recombinant
92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary
92/518 Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)
92/520 Rantes (Human, rDNA derived)
92/530 Influenza Antigen A/Texas/36/91
92/582 Influenza anti B/Yamagata/16/88 Serum(sheep)
92/628 Influenza Antigen B/Yamagata/16/88
92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum (sheep)
92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)
92/648 Measles Vaccine (Live)
92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human
92/658 Papain preparation for use with Anti-D preparation 91/562
92/680 Serum amyloid A protein
92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2)
92/738 Influenza Virus infectious A/Shanghai/24/90
92/788 Interleukin-11 (Human, rDNA derived)
92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived)
93/500 Influenza Antigen A/Beijing/32/92
93/516 Influenza Antigen A/Shanghai/24/90
93/518 Influenza anti A/Beijing/32/92 (H3N2) Serum (sheep)
93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum (sheep)
93/526 Batroxobin
93/556 Nerve Growth Factor (Human, rDNA derived)
93/560 Insulin-like growth Factor Binding Protein-3
93/562 Leukaemia Inhibitory Factor (Human, rDNA derived)
93/564 oncostatin M (Human, rDNA derived)
93/566 Interleukin-2 (Mouse, rDNA derived)
93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2)
93/572 Influenza Virus infectious A/Guizhou/54/89 (H3N2)
93/574 Bone morphogenetic Protein-2 (Human, rDNA derived)
93/668 Interleukin-1 beta (Mouse, rDNA derived)
93/672 Interleukin-1 alpha (Mouse, rDNA derived)
93/686 Influenza Virus infectious A/Shangdong/9/93 (H3N2)
93/692 Influenza Virus infectious B/Panama/45/90
93/722 Interleukin-10 (Human rDNA derived)
93/730 Interleukin-6 (Mouse, rDNA derived)
93/740 Interleukin-7 (Mouse, rDNA derived)
93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2)
94/500 Influenza Antigen B/Panama/45/90
94/504 Influenza anti A/Shanghai/9/93 Serum(sheep)
94/516 Influenza Antigen A/Shangdong/9/93
94/520 Influenza anti B/Panama/45/90 Serum(sheep)
94/532 Pertussis Vaccine (Whole Cell)
94/572 Ferritin, Human, recombinant
94/622 Interleukin-13 (Human, rDNA derived)
94/674 Thyroid Stimulating Hormone, Human recombinant
94/684 Ciliary Neurotrophic Factor (Human, rDNA derived)
94/718 Staphylokinase, rec (STAR)
94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived)
94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma
94/754 Interferon Omega (Human, rDNA derived)
94/762 Influenza Virus infectious RESVIR-8 (H3N2)
94/766 Influenza Virus infectious NIB-34 (H3N2)
94/784 Interferon alpha (Human, leukocyte derived)
94/786 Interferon alpha Concensus Sequence (Human rDNA derived)
94/790 MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C
95/500 Hepatitis A Vaccine, inactivated
95/510 Influenza Antigen A/Texas/36/91
95/516 Influenza Antigen A/Johannesburg/33/94
95/522 Anti-HBc (Anti-hepatitis B core antigen)
95/524 Influenza anti A/Johannesburg/33/94 Serum(sheep)
95/528 Folate, Whole Blood Haemolysate
95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C
95/544 Interleukin-12 (Human, rDNA derived)
95/554 Interleukin-15 (Human, rDNA derived)
95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)
95/566 Interferon alpha-2b (Human, rDNA derived)
95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived)
95/572 Interferon alpha-1/8 (Human, rDNA derived)
95/574 Interferon Alpha n3 (Human, leukocyte derived)
95/580 Interferon alpha-2c (Human, rDNA derived)
95/584 Anti-hepatitis E Serum, Human
95/646 Parathyroid Hormone 1-84, human, recombinant(1st International Standard)
95/650 Interferon alpha-2a (Human, rDNA derived)
95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)
95/674 Anti-Meningococcal Serogroup A mAb
95/678 Anti-Meningococcal Serogroup C mAb
96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)
96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived)
96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived)
96/538 Insulin-like growth Factor-II (Human rDNA derived)
96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived)
96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived)
96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C
96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C
96/602 Luteinizing Hormone, Human, recombinant
96/666 Anti-Human Globulin
96/668 Prostate Specific Antigen (free)
96/784 Inhibin B, Human
96/830 Influenza Virus infectious A/Bayern/7/95
96/836 Influenza Virus infectious RESVIR-9 (H3N2)
96/848 Influenza Virus infectious A/Shenzhen/227/95 (H1N1)
96/850 Influenza Virus infectious NIB-39 (H1N1)
97/518 Influenza Antigen A/Johannesburg/82/96
97/538 Anti-Granulocyte Macrophage colony Stimulating Factor Serum
97/550 Islet Cell Antibodies
97/558 Bordetella pertussis anti 69kD serum (sheep)
97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)
97/564 Bordetella pertussis anti FHA serum (sheep)
97/572 Bordetella pertussis PT anti serum (sheep)
97/574 Bordetella pertussis anti Fim3 serum (sheep)
97/584 Influenza Antigen A/Equine/Newmarket/2/93
97/594 Leptin, Human, Recombinant
97/596 Influenza Antigen A/Equine/Newmarket/1/93
97/600 Interleukin-2 Soluble Receptor (human, rDNA derived)
97/610 Influenza anti A/equine/Newmarket/1/93 Serum(sheep)
97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum
97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)
97/626 Leptin, Mouse, Recombinant
97/642 Bordetella pertussis anti serum (mouse) 1RR
97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041)
97/648 Anti-Measles serum (3rd International Standard)
97/662 Anti-Streptolylsin-O, Human,
97/692 Influenza Virus infectious IVR-108 (H3N2)
97/714 Prolactin, Human, recombinant
97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)
97/726 Influenza Virus infectious B/Harbin/7/94
97/748 Influenza Antigen B/Harbin/7/94
97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G
97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G
97/760 Influenza Antigen A/Beijing/262/95
98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G
98/544 Influenza Virus infectious RESVIR-13 (H3N2)
98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum
98/574 Somatropin
98/580 Prolactin Human, recombinant, glycosylated
98/582 Prolactin, Human, recombinant, non-glycosylated
98/586 Calcitonin, Salmon
98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G
98/600 Influenza Virus infectious NIB-40 (H5N3)
98/604 Influenza anti B/Harbin/7/94/HA Serum (sheep)
98/610 Influenza Virus infectious ARIV-1 (H5N3)
98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)
98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)
98/708 Haemiglobincyanide
98/714 Tissue Plasminogen Activator, Human, Recombinant
98/718 Neurotrophin 3
98/722 Meningococcal group A polysaccharide
98/762 Influenza Virus infectious Resvir-14 (H3N2)
98/772 Influenza anti A/Beijing/262/95 Serum (sheep)
98/774 Influenza Antigen B/Shangdong/7/97
98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2)
99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7)
99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7)
99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11)
99/512 Anti-PT S1 subunit Monoclonal Antibody (10D6)
99/514 Anti-PT S1 subunit Monoclonal Antibody (8G4)
99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E)
99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E)
99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10)
99/522 Anti-PT S1 subunit Monoclonal Antibody (11D9)
99/524 Anti-PT S1 subunit Monoclonal Antibody (4D10)
99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6)
99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9)
99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5)
99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A)
99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6)
99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12)
99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3)
99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8)
99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10)
99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11)
99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5)
99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12)
99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8)
99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2)
99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3)
99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8)
99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3)
99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2)
99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6)
99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6)
99/568 Anti-PT S5 subunit Monoclonal Antibody (7E3)
99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)
99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)
99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)
99/586 Influenza Antigen B/Yamanashi/166/98
99/614 Influenza Antigen A/Sydney/5/97
99/616 Yellow Fever Vaccine
99/624 Influenza Antigen A/Sydney/5/97
99/634-007 HIV-1 RNA Working Reagent 1 (PWS-1) for NAT Assays
99/636-007 HIV-1 RNA Working Reagent 2 for NAT assays
99/642 Chorionic Gonadotrophin, nicked, human
99/650 Chorionic Gonadotrophin, beta subunit, human
99/666 Anti-HPA-5b (Minimum Potency)
99/674-015 HIV-2 (antibody) Monitor Sample
99/686 Parvovirus B19 DNA Reference Material for Nucleic Acid Amplification Techniques
99/688 Chorionic Gonadatrophin, intact, Human
99/692 Chorionic Gonadotrophin, nicked beta subunit, Human
99/706 Anti-Meningococcal human reference serum CDC1992
99/708 Chorionic Gonadatrophin, beta core fragment, Human
99/710-019 HIV-1 (antibody) (1 in 5 dilution) British Working Standard
99/714 Influenza Antigen A/Singapore/1/57 (H2N2)
99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified)
99/728 Anti-D Immunoglobulin Control
99/750-020 HIV-1 (antibody) British Working Standard)
99/824 Influenza Virus infectious RESVIR 16 (H3N2)
99/828 Influenza Antigen B/Yamanashi/166/98
99/836 Anti-D Minimum Potency Standard for blood grouping reagents
AFP Alpha-Foetoprotein
B2M Beta-2 Microglobulin
BUSB Botulinum Antitoxin Equine Type B
CDS Anti-Canine Distemper Serum
CHAN Cholera Antitoxin, Goat
CHS Anti-Canine Hepatitis Serum
COT Clostridium novyi (alpha) Toxoid
CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT
CWEPSILONTD Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT
DY Anti-Dysentery (shiga) serum, Equine
JNIH-11 Bordetella pertussis anti FHA serum (mouse)
JNIH-12 Bordetella pertussis PT( LPF) anti serum, (mouse)
JNIH-3 Acellular Pertussis Vaccine - 1st IS
JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA)
JNIH-5 Bordetella pertussis toxin (PT) 1st IS
MEF/001 Primary Mouse Embryo Fibroblasts (p0)
MGDS Anti-Mycoplasma gallisepticum Serum
NDS Anti-Newcastle Disease Serum
NVIA Newcastle Disease Vaccine (Inactivated)
OE Gas Gangrene Antitoxin (Cl. novyi), Equine
PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine
PPDA Purified Protein Derivative (PPD) of M Avium Tuberculin
PPDBOV Purified Protein Derivative (PPD) of Bovine Tuberculin
PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin
QF Anti-Q Fever Serum, Bovine
RAI Anti-rabies Immunoglobulin, Human
RBT/05 Thromboplastin,rabbit,plain(pack of 5 ampoules) with diluent (pack of 5 04/210)
RTF/09 Thromboplastin, Human Recombinant, Plain (4th I.S.) (Panel of 5 ampoules for use with 5 diluent 08/146).
RUBI-1-94 Anti-rubella Immunoglobulin, Human
SES Swine Erysipelas Serum (anti-N)
SFS Anti-Swine Fever Serum
SMV Smallpox Vaccine
SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S)
SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V)
SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine
SS-319/20 FITC CD4 Positive Control Cells
SSCLOT4 SSC/ISTH Secondary Coagulation Standard Lot#4
STA Staphylococcus Alpha Antitoxin, Equine
STT Diphtheria (Schick) Test Toxin
TE-3 Tetanus Immunoglobulin, Human
TILI Anti-tick borne encephalitis serum (Louping Ill)
TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov)
TOXM Anti-Toxoplasma Serum, Human
TYVK Typhoid Vaccine (acetone-inactivated)
TYVL Typhoid Vaccine (heat-phenol-inactivated)
VI Gas Gangrene Antitoxin (Cl. Septicum), Equine
W1004 Anti-C complete blood typing serum,human
關(guān)鍵字： NIBSC標(biāo)準(zhǔn)品；WHO標(biāo)準(zhǔn)品；世界衛(wèi)生組織國(guó)際生物標(biāo)準(zhǔn)物質(zhì)
大連立方化學(xué)技術(shù)有限公司是國(guó)內(nèi)領(lǐng)先的實(shí)驗(yàn)室試劑、耗材供應(yīng)商，公司主要經(jīng)營(yíng)醫(yī)藥標(biāo)準(zhǔn)品、化工環(huán)境標(biāo)準(zhǔn)品、生物類標(biāo)準(zhǔn)品、原研制劑、高端試劑、植物提取物、實(shí)驗(yàn)室耗材等。公司實(shí)力雄厚，同時(shí)與眾多國(guó)際知名醫(yī)藥企業(yè)、大學(xué)院校、檢測(cè)機(jī)構(gòu)等建立了良好的合作關(guān)系。
公司能夠提供超過(guò)1000000種的有機(jī)和無(wú)機(jī)標(biāo)準(zhǔn)品或試劑，產(chǎn)品涉及藥企，科研單位，檢測(cè)機(jī)構(gòu)，工廠實(shí)驗(yàn)室和高校等絕大部分科研單位；同時(shí)提供優(yōu)質(zhì)、高效的咨詢服務(wù)，助力客戶順利完成實(shí)驗(yàn)和生產(chǎn)任務(wù)。
除此之外，大連立方化學(xué)（LFC）擁有一流的自主研發(fā)能力和生產(chǎn)能力，為石油、化工、發(fā)電、冶金、機(jī)械、重工、船舶等相關(guān)行業(yè)提供全面的水處理技術(shù)解決方案、產(chǎn)品和服務(wù)。